Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / Germany

Shire To Market Orphan Drug Following Jerini Acquisition

July 2008 | Company News Alert

Not wanting to be left behind in the current spate of biotech acquisitions, UK based Shire has struck a deal to acquire German firm Jerini for EUR349mn (US$548mn). In what Jerini describes as a strategic partnership, the UK firm will pay EUR6.25 (US$9.81) per share - 73% more than Jerini's closing price on July 2

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *


If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.

Free Trial To Pharmaceuticals & Healthcare Insight

TAKE A TRIAL >>
Western Europe InsightWestern Europe Channels Western Europe Countries